Colorectal Neoplasms: all 5,738 studies

Page 20 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.

• Decision Aid to Technologically Enhance Shared Decision MakingCompletedNCT01514786Not applicableResults posted
• Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)TerminatedNCT01507545Phase 2Results posted
• Randomized Phase II Adjuvant Chemotherapy ± FANG™ in Colorectal Carcinoma With Liver MetastasesTerminatedNCT01505166Phase 2Results posted
• Panitumumab and Bortezomib for Patients With Advanced Colorectal CancerTerminatedNCT01504477Phase 1/2Results posted
• A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)CompletedNCT01490866Phase 2Results posted
• Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)CompletedNCT01483144Phase 3Results posted
• Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal CancerCompletedNCT01483027Not applicableResults posted
• Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal AdenocarcinomaTerminatedNCT01479465Phase 2Results posted
• A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line TherapyCompletedNCT01478594Phase 2Results posted
• Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal CancerCompletedNCT01471353Phase 2Results posted
• Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary CareCompletedNCT01468675Not applicableResults posted
• Improving Rates of Repeat Colorectal Cancer ScreeningCompletedNCT01453894Not applicableResults posted
• A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced CancersCompletedNCT01451632Phase 1Results posted
• Cetuximab in Refractory Colorectal Cancer With K-RAS Mutated and Favorable FcγRIIa (CD32) GenotypeCompletedNCT01450319Phase 2Results posted
• Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaCompletedNCT01444456Results posted
• An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon CancerCompletedNCT01442155Results posted
• Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal CancerCompletedNCT01412957Phase 3Results posted
• An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal CancerCompletedNCT01399190Results posted
• Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and CancerCompletedNCT01397747Results posted
• Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaCompletedNCT01394939Phase 1/2Results posted
• Effectiveness of Direct-to-Patient Outreach on Colorectal Cancer Screening Within a Low Income and Diverse PopulationCompletedNCT01385579Not applicableResults posted
• A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal CancerCompletedNCT01383707Phase 2Results posted
• Phase 1b Dose Escalation Study of Intravenous JX-594 in Metastatic, Refractory Colorectal CarcinomaCompletedNCT01380600Phase 1Results posted
• Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)CompletedNCT01374425Phase 2Results posted
• Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGFTerminatedNCT01367275Phase 2Results posted
• Ginger for Colorectal Cancer PreventionCompletedNCT01344538Phase 2Results posted
• An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver MetastasesCompletedNCT01343901Results posted
• MK-2206 and AZD6244 in Patients With Advanced Colorectal CarcinomaCompletedNCT01333475Phase 2Results posted
• Neoadjuvant Recombinant Vaccinia Virus for Metastatic Colorectal Cancer With Liver ResectionTerminatedNCT01329809Phase 2Results posted
• Colonoscope Insertion Trial ProtocolCompletedNCT01324882Not applicableResults posted
• An Observational Study of Bevacizumab in Combination With 5-FU-Based Chemotherapy in Chinese Participants With Metastatic Colorectal CancerCompletedNCT01319877Results posted
• Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal CancerCompletedNCT01312857Phase 2Results posted
• Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMICompletedNCT01312467Phase 2Results posted
• Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy StudyCompletedNCT01310699Not applicableResults posted
• Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal CancerCompletedNCT01298570Phase 2Results posted
• Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver MetastasesCompletedNCT01290536Phase 2Results posted
• First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With RegorafenibCompletedNCT01289821Phase 2Results posted
• Clinical Study of Real Time Colorectal Polyp Diagnosis During Colonoscopy - the VALID Colonoscopy StudyCompletedNCT01288833Not applicableResults posted
• A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)CompletedNCT01286818Phase 1Results posted
• Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal CancerTerminatedNCT01280643Not applicableResults posted
• Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal CancerTerminatedNCT01279681Phase 3Results posted
• Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + CetuximabCompletedNCT01276379Phase 2Results posted
• Cetuximab Standard or Dose Escalation in First Line Colorectal CancerCompletedNCT01251536Phase 2Results posted
• A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type PatientsCompletedNCT01228734Phase 3Results posted
• FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases OnlyCompletedNCT01226719Phase 2Results posted
• A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal CancerCompletedNCT01220999Phase 1Results posted
• Physical Activity for Reduction of Recurrence Rate After Adjuvant Chemotherapy for Localised Colorectal CarcinomaCompletedNCT01210313Results posted
• High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal CancerTerminatedNCT01198548Phase 2Results posted
• Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With PolyposisCompletedNCT01197612Phase 3Results posted
• Azacitidine and CAPOX in Metastatic Colorectal CancerCompletedNCT01193517Phase 1/2Results posted
• Increasing Colorectal Cancer Screening in a Safety-net Health System With a Focus on the Uninsured: Benefits and CostsCompletedNCT01191411Not applicableResults posted
• Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By SurgeryTerminatedNCT01189227Phase 3Results posted
• A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis PatientsCompletedNCT01187901Phase 2Results posted
• Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal CancerTerminatedNCT01186705Phase 2Results posted
• A Study in Second Line Metastatic Colorectal CancerCompletedNCT01183780Phase 3Results posted
• A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or RectumCompletedNCT01181609Phase 2Results posted
• Improvement of Fluid Balance in Patients Undergoing Surgery of the Colon and RectumCompletedNCT01175317Phase 4Results posted
• A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer.CompletedNCT01159171Phase 2Results posted
• Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal CancerCompletedNCT01154335Phase 1Results posted
• A Study of BIBW 2992 (Afatinib) in Patients With Metastatic Colorectal CancerCompletedNCT01152437Phase 2Results posted
• Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With SurgeryCompletedNCT01150045Phase 3Results posted
• QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEACompletedNCT01147965Phase 1/2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.CompletedNCT01135498Phase 2Results posted
• FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal CancerTerminatedNCT01133990Phase 1/2Results posted
• A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or RectumCompletedNCT01131078Phase 2Results posted
• Sym004 in Patients With Advanced Solid TumorsCompletedNCT01117428Phase 1/2Results posted
• A Study of Ramucirumab or Icrucumab in Colorectal CancerCompletedNCT01111604Phase 2Results posted
• Precision-Based Magnesium TrialCompletedNCT01105169Not applicableResults posted
• Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer ScreeningCompletedNCT01103479Phase 2/3Results posted
• Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard TherapyCompletedNCT01103323Phase 3Results posted
• A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the LiverTerminatedNCT01098422Not applicableResults posted
• Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART)CompletedNCT01089413Results posted
• MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)TerminatedNCT01085331Phase 1/2Results posted
• Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing ChemotherapyCompletedNCT01079780Phase 2Results posted
• A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and AvastinCompletedNCT01077739Phase 2Results posted
• ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal CancerCompletedNCT01075048Phase 1/2Results posted
• Vitamin D Levels in Stage IV Colorectal Cancer PatientsCompletedNCT01074216Phase 2Results posted
• RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal CancerCompletedNCT01058655Phase 1/2Results posted
• First-Line FOLFOX-Bevacizumab for Advanced Colorectal Cancer With Wild-Type RasTerminatedNCT01057017Phase 2Results posted
• Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal CancerCompletedNCT01053013Phase 2Results posted
• A Study of ABT-888 in Combination With Temozolomide for Colorectal CancerCompletedNCT01051596Phase 2Results posted
• A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer (FDA IND 103675)CompletedNCT01047475Phase 2Results posted
• RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal CarcinomaCompletedNCT01047293Phase 1/2Results posted
• Third Eye Retroscope Randomized Clinical EvaluationCompletedNCT01044732Not applicableResults posted
• A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal CancerTerminatedNCT01032291Phase 2Results posted
• EMD 525797 in Combination With Cetuximab and Irinotecan in K-ras Wild Type Metastatic Colorectal CancerCompletedNCT01008475Phase 1/2Results posted
• Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal CancerCompletedNCT01006369Phase 2Results posted
• Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus IrinotecanTerminatedNCT01004159Phase 2Results posted
• ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerCompletedNCT01001377Phase 3Results posted
• Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line ChemotherapyTerminatedNCT00986440Phase 2Results posted
• Adherence to a Recommended Exercise Regimen in Colorectal Cancer PatientsCompletedNCT00977613Not applicableResults posted
• Figitumumab Combined With Pegvisomant For Advanced Solid TumorsTerminatedNCT00976508Phase 1Results posted
• Impact of Experience on Results With the Third Eye RetroscopeCompletedNCT00969124Not applicableResults posted
• Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line TherapyCompletedNCT00967616Phase 2Results posted
• Sunitinib and Capecitabine for First Line Colon CancerTerminatedNCT00961571Phase 2Results posted
• A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer StudyCompletedNCT00959647Phase 2Results posted
• Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal CancerCompletedNCT00940316Phase 2Results posted
• Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)CompletedNCT00927485Not applicableResults posted
• Phase I Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Participants With Colorectal Cancer (MK-0646-016)CompletedNCT00925015Phase 1Results posted
• A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...CompletedNCT00923481Phase 2Results posted

← Colorectal Neoplasms overview